KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Receivables (2016 - 2025)

Petmed Express' Receivables history spans 15 years, with the latest figure at $1.6 million for Q4 2025.

  • For Q4 2025, Receivables fell 30.99% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.6 million, down 30.99%, while the annual FY2025 figure was $2.3 million, 29.42% down from the prior year.
  • Receivables reached $1.6 million in Q4 2025 per PETS's latest filing, down from $2.0 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $3.3 million in Q1 2024 to a low of $1.3 million in Q4 2021.
  • Average Receivables over 5 years is $2.0 million, with a median of $1.9 million recorded in 2022.
  • Peak YoY movement for Receivables: plummeted 32.68% in 2021, then surged 88.68% in 2024.
  • A 5-year view of Receivables shows it stood at $1.3 million in 2021, then surged by 53.43% to $1.9 million in 2022, then fell by 0.72% to $1.9 million in 2023, then rose by 17.05% to $2.3 million in 2024, then tumbled by 30.99% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's Receivables are $1.6 million (Q4 2025), $2.0 million (Q3 2025), and $1.6 million (Q2 2025).